Clinical benefits of leukocyte filtration during valve surgery

American Journal of Surgery

Volumn 186, Issue 6, 2003, Pages 636-640

  Patel, Amit N ^a   Sutton, Steven W ^a   Livingston, Sheryl ^a   Patel, Amy ^a   Hunley, Eric K ^a   Hebeler, Robert F ^a   Henry III, A Carl ^a   Hamman, Baron L ^a   Wood, Richard E ^a   Urschel Jr , Harold C ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Filtration; Leukocyte; Surgery; Valve

Indexed keywords

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTERIAL GAS; ARTICLE; CARDIOPULMONARY BYPASS; CELL SEPARATION; COHORT ANALYSIS; CONTROLLED STUDY; EXTUBATION; FEMALE; GENERAL CONDITION IMPROVEMENT; HEART VALVE SURGERY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE; LEUKOCYTE COUNT; LIMB; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY QUOTIENT; SURGICAL PATIENT; THROMBOCYTE COUNT; TIME; TREATMENT OUTCOME; TRICUSPID VALVE DISEASE;

EID: 10744231982     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2003.09.001     Document Type: Article

References (12)

1. Edmunds L.H., Clark R.E., Cohn L.H., et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg. 46:1988;257-259.
2. Gibbon J.H. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 37:1954;171-185.
3. Bukley G.B. Reactive oxygen metabolites and reperfusion injury aberrant triggering of reticuloendothelial function . Lancet. 344:1994;934-936.
4. Kirklin J.K. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg. 51:1991;529-531.
5. Maggart M., Stewart S. The mechanisms and management of non-cardiogenic pulmonary edema following cardiopulmonary bypass. Ann Thorac Surg. 43:1987;231-236.
6. Shapira N., Zabatino S.M., Ahmed S., et al. Determinants of pulmonary function in patients undergoing coronary bypass operations. Ann Thorac Surg. 50:1990;268-273.
7. Sheppard SV. Mechanisms and technical aspects of leukocyte depletion. In: Sheppard SV, editor. Leukocyte depletion in cardiac surgery and cardiology. 2002, p 16-32.
8. Taylor G.J., Mikell F.L., Moses H.W., et al. Determinants of hospital charges for coronary artery bypass surgery the economic consequences of postoperative complications . Am J Card. 65:1990;309-313.
9. Lust R.M., Bode A.P., Yang L., et al. In-line leukocyte filtration during bypass. Clinical results from a randomized prospective trial. ASAIO J. 42:1996;M819-822.
10. Gu Y.J., de Vries A.J., Boonstra P.W., van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg. 112:1996;494-500.
11. Mihaljevic T., Tonz M., von Segesser L.K., et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study. J Thorac Cardiovasc Surg. 109:1995;1138-1145.
12. Efstathiou A., Vlachveis M., Tsonis G., et al. Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome? J Cardiovasc Surg (Torino). 44:2003;197-204.